
Accelerate preclinical discovery with a predictive, high-throughput model. Our zebrafish platform enables rapid, cost-effective evaluation of candidate compounds across diverse disease models, delivering insights that de-risk pipelines and guide smarter development decisions.
Price | 3500€+ |
Organism | Zebrafish (Danio rerio) |
Product Type | – |
Tissue | – |
Disease | Parkinson’s Disease, Epilepsy, Anxiety & Depression, Cancer |
Applications
Drug screening

With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...

Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...

Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
Among the many fermented foods we consume, kimchi is particularly known for containing a diverse range of lactic acid bacteria, which are believed to influence the activation of immune cells...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Our Zebrafish Efficacy Testing service provides a state-of-the-art platform for validating the effectiveness of candidate substances across various disease models using versatile zebrafish. This method offers a rapid and ethical alternative to traditional animal testing, ideal for pharmaceutical development and biomedical research.

Zebrafish (Danio rerio) are gaining recognition as a rapid, cost-effective, and ethical model for early-stage in vivo drug evaluation.
Their high genetic similarity to humans and external development allow for real-time physiological observation and efficient compound screening.
Lambda Biologics utilizes zebrafish to rapidly assess compound safety, efficacy, and medical relevance.
Since embryos within five days post-fertilization are not classified as animals under regulatory standards, early testing can proceed with minimal ethical constraints.
Zebrafish models are effective for identifying therapeutic targets and generating proof-of-concept data across a range of diseases.
By integrating high-throughput screening with in vivo analysis, this platform delivers fast, reliable insights for preclinical development.
Fast, accurate evaluation of compound effects with scalable high-throughput capabilities.
A more economical alternative to mammalian models, with reproducible data for early-stage development.
Efficacy can be confirmed in as little as two weeks across multiple therapeutic areas.
Behavioral assays, tissue expression studies, EEG, and phenotyping provide comprehensive profiles.
Customized zebrafish models support neurology, oncology, cardiovascular, and other research areas with translatable outcomes.


Using a zebrafish anxiety model, thigmotaxis (preference for swimming along tank walls) was measured as an indicator of anxiety-like behavior.
Representative swim traces show zebrafish movement patterns after treatment with different agents:
– Control (vehicle): baseline behavior with strong peripheral preference.
– Ethanol & Fluoxetine: increased exploration of the center zone, reflecting reduced anxiety.
– Scopolamine: moderate behavioral alteration.
– Yohimbine: pronounced wall-hugging, consistent with anxiogenic effects.
This application demonstrates how zebrafish enable rapid, in vivo assessment of neuroactive compounds, providing translational insights into drug efficacy and side effects.
Explore how zebrafish platforms can support your therapeutic pipeline while reducing costs and ethical barriers.
Connect with our experts to learn more.
Lambda Biologics combines advanced zebrafish models with standardized, high-throughput protocols to deliver reproducible and translatable data. Our team integrates deep biological expertise with customer-focused project design to ensure meaningful results.
Simply reach out to our scientific team. We’ll schedule a discussion to understand your research objectives and propose a tailored zebrafish study design aligned with your goals and timelines.